Approval · Notice of Compliance 13091 · 2012
VELCADE: Notice of Compliance 13091
Issued March 9, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13091
- Date
- March 9, 2012
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New route: subcutaneous injection
- Therapeutic class
- Antineoplastic Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VELCADE | 02262452 | Marketed |
Medicinal ingredients
- BORTEZOMIB MANNITOL BORONIC ESTER 3.5 MG per VIAL